These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6173360)

  • 1. Monoclonal and xenoantibodies specific for HLA-DR inhibit primary responses to HLA-D but fail to inhibit secondary proliferative (PLT) responses to allogeneic cells.
    Eckels DD; Woody JN; Hartzman RJ
    Hum Immunol; 1981 Oct; 3(2):133-42. PubMed ID: 6173360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of polyclonal and monoclonal HLA-DR xenoantibodies on xenogeneic mixed lymphocyte reactions.
    Russo C; Quaranta V; Indiveri F; Pellegrino MA; Ferrone S
    Immunogenetics; 1980; 11(4):413-6. PubMed ID: 6448810
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of autologous mixed lymphocyte reaction by monoclonal antibodies specific for the beta chain of HLA-DR antigens.
    Kasahara M; Ikeda H; Ogasawara K; Ishikawa N; Okuyama T; Fukasawa Y; Kojima H; Kunikane H; Hawkin S; Ohhashi T
    Immunology; 1984 Sep; 53(1):79-86. PubMed ID: 6205985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of shared lymphocyte-stimulating determinants between H-2I and HLA-D/DR using mouse primed lymphocyte typing cells.
    Shaut DM; Ireland J; Scornik JC; Peck AB
    Hum Immunol; 1983 Jun; 7(2):105-15. PubMed ID: 6190790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.
    Zeevi A; Scheffel C; Annen K; Bass G; Marrari M; Duquesnoy RJ
    Immunogenetics; 1982; 16(3):209-18. PubMed ID: 6183198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The new HLA-DRw6- and 8- associated HLA-Dw HAG specificity defined by homozygous typing cell 9W 1802. Analysis with primed lymphocyte typing clones.
    Pawelec G; Müller C; Rehbein A; Balko I; Schunter F; Wernet P
    Tissue Antigens; 1984 Nov; 24(5):292-301. PubMed ID: 6085195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of primary MLC of the non HLA-D/DR determinant PL3A.
    Termijtelen A; van Rood JJ
    Tissue Antigens; 1981 Jan; 17(1):57-63. PubMed ID: 6166084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-D restriction of antigen-specific proliferative T cell responses. Inhibitory activity of antisera against HLA determinants or stimulatory antigen.
    Thorsby E; Ferrone S; Nousiainen H; Hirschberg H
    Tissue Antigens; 1983 Feb; 21(2):148-58. PubMed ID: 6189261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavior of HLA-DR homozygous cells in MLC and PLT.
    Zier KS; Gansbacher B; Scholz S; Albert E
    Transplant Proc; 1981 Mar; 13(1 Pt 2):1035-8. PubMed ID: 6168061
    [No Abstract]   [Full Text] [Related]  

  • 11. Idiotype-like determinants on human T lymphocytes alloactivated in mixed lymphocyte culture.
    Suciu-Foca N; Rohowsky C; Kung P; King DW
    J Exp Med; 1982 Jul; 156(1):283-8. PubMed ID: 6177823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR antigens render interleukin-2-producer T lymphocytes sensitive to interleukin-1.
    Palacios R
    Scand J Immunol; 1981 Sep; 14(3):321-6. PubMed ID: 6173920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexity of the HLA-D region studied by primed-lymphocyte test.
    Segall M; Reinsmoen NL; Noreen HJ; Bach FH
    J Exp Med; 1980 Aug; 152(2 Pt 2):156s-163s. PubMed ID: 6157765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactive T cells: expression of HLA-D antigens, stimulation of autologous MLR, and possible immunoregulatory function.
    Suciu-Foca N; Rohowsky C; Coburn C; Reed E; Khan R; Lewison A
    Hum Immunol; 1981 Dec; 3(4):301-12. PubMed ID: 6460016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation in primary MLR caused by a PLT defined non-HLA-D/DR determinant, EP1.
    Holter W; Morling N
    Tissue Antigens; 1983 Jul; 22(1):42-8. PubMed ID: 6193606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reactions of primed lymphocytes (PLT) and their genetic determination (author's transl)].
    Hajek-Rosenmayr A
    Wien Klin Wochenschr; 1982 Jan; 94(1):13-9. PubMed ID: 6177103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra HLA-D/DR region recombinant detected by primed lymphocyte typing (PLT).
    Jakobsen BK; Kristensen T; Lamm LU; Morling N; Bruun-Petersen G; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1983 Aug; 22(2):123-33. PubMed ID: 6578608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both HLA-DR and HLA-DQ determinants contribute to HLA-Dw typing.
    Sterkers G; Zeliszewski D; Freidel AC; Gebuhrer L; Betuel H; Levy JP
    Hum Immunol; 1987 Nov; 20(3):233-47. PubMed ID: 2449409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody detecting an HLA-DQwl-related determinant.
    Koning F; Raghoebar J; Schreuder GM; Schuurman R; Bruning H
    Tissue Antigens; 1985 Aug; 26(2):100-9. PubMed ID: 2414859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-D and -DR antigens on human amniotic fluid cells. I. Lack of expression of HLA-D.
    Valentine-Thon E; Kreeb G; Grosse-Wilde H; Passarge E
    Tissue Antigens; 1983 Feb; 21(2):138-47. PubMed ID: 6221440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.